Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Urethral Stricture Treatment Devices Market Growth Analysis: How Will Revenue Trend Over The Forecast Period?
The market for urethral stricture treatment devices has demonstrated robust growth in recent years. Its valuation is expected to increase from $1.47 billion in 2025 to $1.59 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 8.0%. This historical expansion can be attributed to factors such as a rise in urological disorders, the aging male population, an increase in catheterization procedures, the expansion of hospital urology departments, and surgical stricture treatments.
The urethral stricture treatment devices market is projected to experience significant expansion in the upcoming years. Its value is expected to reach $2.14 billion in 2030, growing at a compound annual growth rate (CAGR) of 7.8%. This anticipated growth during the forecast period stems from factors such as an increase in minimally invasive urology, the demand for long-term stent solutions, the adoption of advanced biomaterials, the expansion of outpatient procedures, and the emergence of personalized urology devices. Prominent trends expected in this period encompass minimally invasive stricture management, advancements in balloon dilation technologies, sophisticated urethral stents, better catheter materials, and the growing prevalence of outpatient urology procedures.
Get A Free Sample Report With In-Depth Market Insights:
Urethral Stricture Treatment Devices Market Demand Drivers: What’s Powering Industry Growth?
The increasing incidence of benign prostatic hyperplasia (BPH) and neurogenic bladder is anticipated to boost the urethral stricture treatment devices market moving forward. BPH is a common condition among older men, characterized by an enlarged prostate gland that frequently causes urinary obstruction and heightens the risk of urethral strictures. The growing prevalence of benign prostatic hyperplasia (BPH) is primarily due to aging, with higher rates observed in men over 50, while lifestyle, hormonal changes, and chronic conditions also contribute to its progression. Urethral stricture treatment devices are commonly utilized for urological conditions such as benign prostatic hyperplasia (BPH), where complications following surgery or extended catheter use can lead to urethral narrowing, requiring interventions like dilators, stents, or urethrotomy tools to restore normal urinary flow. For instance, in September 2023, a report from the Royal Pharmaceutical Society, a professional body based in the UK, revealed that approximately 3 million people in the UK are affected by BPH, with its occurrence estimated at around 50% in males aged 60–70 years and rising to 90% in males aged over 80 years. Hence, the rising prevalence of BPH and neurogenic bladder will drive the urethral stricture treatment device market.
Urethral Stricture Treatment Devices Market Segment Trends And Revenue Contributors
The urethral stricture treatment devices market covered in this report is segmented –
1) By Product Type: Urethral Dilators, Urethral Stents, Urethral Balloon Dilation Catheters, Urinary Catheters
2) By Stricture Location: Anterior, Posterior
3) By End-User: Hospitals, Specialty Clinics, Other End-Users
Subsegments:
1) By Urethral Dilators: Semi-Rigid Urethral Dilators, Flexible Urethral Dilators, Balloon Urethral Dilators, Graded Urethral Dilators
2) By Urethral Stents: Self-Expanding Urethral Stents, Balloon-Expandable Urethral Stents, Metallic Urethral Stents, Silicone Urethral Stents
3) By Urethral Balloon Dilation Catheters: Single-Balloon Dilation Catheters, Double-Balloon Dilation Catheters, Coaxial Balloon Dilation Catheters, Hydrophilic-Coated Balloon Dilation Catheters
4) By Urinary Catheters: Foley Urinary Catheters, Intermittent Urinary Catheters, External Urinary Catheters, Supra-Pubic Urinary Catheters
Urethral Stricture Treatment Devices Market Innovation Trends: What Developments Are Reshaping The Industry?
Companies at the forefront of the urethral stricture treatment devices market are strategically pursuing partnerships to enhance technological integration and expand their market reach. A strategic partnership defines a collaborative endeavor between multiple organizations, where they unify their resources, expertise, and efforts toward mutual goals. Illustratively, in April 2024, Laborie Medical Technologies Corp., a US-based company specializing in diagnostic and therapeutic medical technology, established a partnership with the NHS Specialized Services Device Programme (SSDP) to include its Optilume Urethral Drug-Coated Balloon (DCB) within the program. This alliance ensures reimbursement for NHS hospitals in England, thereby expanding patient access to this novel device. Optilume combines balloon dilation with anti-proliferative drug delivery to reduce the recurrence of urethral strictures. This minimally invasive technology represents a significant advancement over traditional surgery or repeated interventions, addressing a critical need within the urology community.
Urethral Stricture Treatment Devices Market Key Players Shaping Industry Direction
Major companies operating in the urethral stricture treatment devices market are Cardinal Health, Medtronic plc, Siemens Healthineers AG, Medline Industries LP., Becton Dickinson and Company, Stryker Corporation, Boston Scientific Corporation, B. Braun SE, Olympus Corporation, Coloplast Ltd, Teleflex Incorporated, Karl Storz SE & Co. KG, Cook Medical, ConvaTec Inc., Ambu A/S, Richard Wolf GmbH, Laborie Medical Technologies, Bactiguard AB, UROMED Kurt Drews KG, Pnn Medical A/S, Hydrumedical SA, Allium Ltd., Med pro Medical B.V., Urotronic Inc., Rocamed SAM, Zhejiang ChuangXiang Medical Technology Co. Ltd
View The Full Urethral Stricture Treatment Devices Market Report:
Urethral Stricture Treatment Devices Market Regional Analysis: Which Region Leads By Revenue?
North America was the largest region in the urethral stricture treatment devices market in 2025. The regions covered in the urethral stricture treatment devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
